Ageas
17.4.2026 17:40:00 CEST | Globenewswire | Press release
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
As the quorum required for the Extraordinary General Meeting of Shareholders of Wednesday 22 April 2026 will not be attained, ageas SA/NV is organising the Ordinary and Extraordinary General Meetings of Shareholders (the "Meeting") on Wednesday 20 May 2026 at 10:30am. The Meeting is being held at the Auditorium of AG Insurance, AG Campus, in 1000 Brussels, Rue du Pont Neuf 17.
The general conditions for attending the Meeting as well as the below documents are available on the Ageas website:
- the convening notice, together with the agenda containing the items:
- the approval of the annual report and accounts for 2025,
- the approval of the 2025 dividend,
- the discharges of liability,
- the approval of the remuneration report,
- the approval of the proposal for the appointment and reappointments of Board members,
- the acknowledgment of the change of the permanent representative of the statutory auditor,
- the approval of proposed amendments to the Articles of Association (authorised capital), and
- the authorisation for the company to acquire ageas SA/NV shares.
- the special report by the Board of Directors on the use and purpose of the authorized capital prepared in accordance with article 7:199 of the Companies and Associations Code,
- the proxy model,
- the annual report 2025 of ageas SA/NV.
Shareholders will be able to register, vote and ask questions at the Meeting if, on the date of registration, they hold the number of shares for which they have indicated their intention to exercise their voting rights, irrespective of the number of shares they hold on the day of the Meeting. The registration date has been set at Wednesday 6 May 2026 at midnight (CET).
Shareholders who wish to attend the Meeting must make their intentions known no later than Thursday 14 May 2026 by communicating their instructions to the company, their bank or their financial institution. The proxies with which shareholders can pass on their voting instructions must be in the company's possession no later than Thursday 14 May 2026.
Questions about this Meeting can be e-mailed to general.meeting@ageas.com.
Ageas is a listed international insurance Group with a heritage spanning of 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow, and is also engaged in reinsurance activities. As one of Europe's larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, Portugal, Türkiye, China, Malaysia, India, Thailand, Vietnam, Laos, Cambodia, Singapore, and the Philippines through a combination of wholly owned subsidiaries and long-term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of about 55,000 people and reported annual inflows of EUR 19.6 billion in 2025.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chery Group17.4.2026 18:57:23 CEST | Press release
LEPAS European Debut: Where Elegance Meets the Art of Mobility in Milan
Stella33 Srl17.4.2026 18:52:04 CEST | Press release
LIMITLESS WORKSPACE – Where Design Performs
Azerion Group NV17.4.2026 18:24:26 CEST | Press release
Azerion Group publishes its 2025 Annual Report
Genmab A/S17.4.2026 16:56:37 CEST | Press release
Genmab A/S Share Capital Reduction
Pharma Equity Group A/S17.4.2026 16:48:03 CEST | Pressemeddelelse
Forløb af generalforsamlingen i Pharma Equity Group A/S
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom